Frederick R. Ahmann
Impact in
- Pulmonary and Respiratory Medicine top 0.5%
- Prostate Cancer Treatment and Research
- Prostate Cancer Diagnosis and Treatment
- Rheumatology top 1%
- Urologic and reproductive health conditions
Papers in
-
- Prostate Cancer Treatment and Research 25
- Prostate Cancer Diagnosis and Treatment 19
- Oncology 20
- Cancer Treatment and Pharmacology 8
- Co-authors
- Bruce L. DalkinJean B. deKernionPaula C. SouthwickWilliam J. CatàlonaTimothy L. RatliffM’Liss A. HudsonPeter T. ScardinoW. Bedford Waters
- Journals
- The Journal of Urology (15 papers)Cancer (7 papers)Journal of Clinical Oncology (6 papers)Investigational New Drugs (5 papers)Urology (3 papers)
- Partner nations
- United StatesUnited KingdomNetherlands
In The Last Decade
Frederick R. Ahmann
63 papers receiving 3.6k citations
Hit Papers
Peers
Comparison fields: 5 of 122
- Pulmonary and Respiratory Medicine 2.6k
- Rheumatology 718
- Urology 243
- Oncology 804
- Cancer Research 402
Countries citing papers authored by Frederick R. Ahmann
This map shows the geographic impact of Frederick R. Ahmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frederick R. Ahmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frederick R. Ahmann more than expected).
Fields of papers citing papers by Frederick R. Ahmann
This network shows the impact of papers produced by Frederick R. Ahmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frederick R. Ahmann. The network helps show where Frederick R. Ahmann may publish in the future.
Co-authors
The 25 scholars most cited alongside Frederick R. Ahmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 1 | |
| 2 | 2012 | 74 | |
| 3 | 2011 | 128 | |
| 4 | 2010 | 20 | |
| 5 | 2002 | 74 | |
| 6 | 1997 | 10 | |
| 7 | 1996 | 1 | |
| 8 | 1995 | 4 | |
| 9 | 1994 | 16 | |
| 10 | 1993 | 154 | |
| 11 | 1993 | 19 | |
| 12 | 1993 | 5 | |
| 13 | 1992 | 38 | |
| 14 | 1991 | 1 | |
| 15 | 1990 | 19 | |
| 16 | 1988 | 16 | |
| 17 | 1987 | 36 | |
| 18 | 1987 | 53 | |
| 19 | The ATP assay: Anti-cancer drug effects on malignant cell growth | 1985 | 3 |
| 20 | Improved survival of patients with advanced breast cancer treated with adriamycin-cyclophosphamide plus tamoxifen (TAC) | 1981 | 3 |
About Frederick R. Ahmann
Frederick R. Ahmann is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Pathology and Forensic Medicine, Rheumatology and Applied Microbiology and Biotechnology, having authored 65 papers that have together received 3.9k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (25 papers), Prostate Cancer Diagnosis and Treatment (19 papers), Cancer Treatment and Pharmacology (8 papers), Hormonal and reproductive studies (7 papers), Urologic and reproductive health conditions (6 papers), Lymphoma Diagnosis and Treatment (5 papers), Estrogen and related hormone effects (4 papers) and Chemotherapy-induced cardiotoxicity and mitigation (4 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (2.6k citations), Rheumatology (718 citations), Urology (243 citations), Oncology (804 citations) and Cancer Research (402 citations). Frederick R. Ahmann has collaborated with scholars based in United States, United Kingdom and Netherlands. Frequent co-authors include Bruce L. Dalkin, Jean B. deKernion, Paula C. Southwick, William J. Catàlona, Timothy L. Ratliff, M’Liss A. Hudson, Peter T. Scardino, W. Bedford Waters, John P. Richie and Ron B. Schifman. Their work appears in journals such as The Journal of Urology, Cancer, Journal of Clinical Oncology, Investigational New Drugs and Urology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.